CME Group has sued the U.S. Commodity Futures Trading Commission and its chair, Michael Selig, challenging the regulator’s recent approvals of crypto perpetual futures — a move that thrusts a previously offshore-dominated market onto U.S. soil.
What happened
- The lawsuit, filed after the CFTC approved several regulated perpetual products, argues the agency improperly classified perpetual contracts as futures rather than swaps. CME says that classification conflicts with the swap framework Congress created under the Dodd‑Frank Act.
- The dispute centers in part on Kalshi’s Bitcoin perpetual (BTCPERP), which the CFTC cleared on May 29. The regulator said the product may remain listed so long as it complies with the Commodity Exchange Act and existing CFTC rules, while warning that perpetual structures may not suit every asset class and that each product will be reviewed individually.
- Kalshi quickly expanded beyond Bitcoin to offer perpetuals tied to Ethereum, XRP, and Hyperliquid — and disclosed its perpetual business generated more than $5.5 billion in trading volume within weeks of launch. Other market entrants include Coinbase, which secured a U.S. route to offer some perpetuals using infrastructure tied to Deribit.
CME’s claims
- CEO Terrence Duffy publicly said the firm would sue after the CFTC cleared platforms including Kalshi and Coinbase. CME’s complaint alleges the agency departed from its historical treatment of similar instruments (pointing to prior CFTC actions that treated perpetual-style products as swaps) and sidestepped the formal rulemaking process Congress intended for swaps.
- The filing also raises intellectual property and licensing issues: CME says it holds exclusive benchmark-provider agreements and argues related products should be routed through its markets regardless of contract structure.
CFTC response and wider context
- A CFTC spokesperson told Bloomberg that CME chose litigation instead of competing in the market, framing the suit as resistance to a pro‑innovation regulatory approach that increases competition for established players.
- The CFTC has emphasized its approvals are being handled on a product-by-product basis and cautioned that perpetuals aren’t automatically appropriate for every asset class.
Legal analysis — an uncertain road ahead
- Katherine Kirkpatrick, general counsel at StarkWare, noted the legal outcome is far from certain. She observed that courts now defer less to agencies on statutory interpretation (post Loper Bright), which could help CME’s argument — but also means past enforcement positions (such as the CFTC’s treatment of perps in its Binance case) aren’t binding precedent.
- Kirkpatrick added that federal law doesn’t necessarily require the CFTC to wait a set period or maintain a quorum before acting, suggesting the chair may have authority to approve products. She also said CME must still prove concrete competitive harm, and that offshore perpetual venues already compete with U.S. exchanges. Given perpetuals are a relatively new product class, she argued Congress likely did not explicitly address them in Dodd‑Frank, leaving the CFTC some discretion to classify novel instruments.
Why it matters
- This lawsuit could define how key crypto derivatives are regulated in the U.S. — whether perpetual contracts are treated as futures available to U.S. exchanges, or as swaps subject to a different statutory regime and oversight. The decision will influence where crypto derivatives trade, how incumbents compete with new entrants, and how quickly U.S. markets can scale products that have already drawn billions in volume.
We’ll continue to follow filings and regulatory responses as the case develops.
Read more AI-generated news on: undefined/news
